This 24-month, open-label, active-controlled, comparative international study, was the largest since the 1979 Hogarty study to compare the relapse rates of a long-acting injectable antipsychotic and an oral
In addition, the FDA has designated Lev’s complete response as a Class 2 resubmission, establishing an October 14, 2008 target action date to complete its review of the
As a result of these actions, Neuralstem is asking for a declaratory judgment that the patent is unenforceable. The suit was filed in the US District Court of
In studies recently initiated by researchers, high concentrations of monkeypox virus (MPV) (approximately 35 thousand cpu/ml) were rapidly depleted from cell culture fluids when circulated through the Hemopurifier.
This double-blind, placebo-controlled, four-week, forced-dose study in 414 adults aged 18 to 55 years showed that treatment with Vyvanse at all doses studied (30mg, 50mg, 70mg) provided a
The objectives of the trial are to define the maximum tolerated dose (MTD) of Cloretazine (VNP40101M) when given in combination with cytarabine to acute myelogenous leukemia (AML) and
The study is designed to provide preliminary information on the potential of Medidur FA to maintain the efficacy established with Lucentis while reducing the overall number of Lucentis
The study met its primary safety endpoint at six months, along with its secondary performance endpoints at six months. The Carillon system is a percutaneous treatment of functional
The priority review designation is intended to expedite the review process for therapies that may provide a significant improvement in the treatment of serious or life-threatening diseases. Based
Under the agreement, initial discussions will focus on developing new tests that could make the biggest impact to patient care. Dave Hickey, senior vice president strategic planning and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.